Jin Yang-gon

HLB Chairman · 10 stocks

Value held (filed)$243M10 direct holdings

30-day netNo change

Holdings

Value Stake Latest filing

HLBdirect 7.15% · indirect 0.03%7.18%$223M

Direct7.15%
HLB Global 11.74% → HLB 0.25%0.03%

HLB innoVationdirect 0.73% · indirect 1.46% · avg $12.34 −13%2.19%$8.2M

Direct0.73%
HLB Pharmaceutical 2.09% → HLB innoVation 7.84%0.16%
HLB bioStep 0.98% → HLB innoVation 2.02%0.02%
HLB 7.15% → HLB bioStep 14.51% → HLB innoVation 2.02%0.02%
HLB 7.15% → HLB Life Science 16.81% → HLB Pharmaceutical 14.05% → HLB innoVation 7.84%0.01%
HLB 7.15% → HLB Life Science 16.81% → HLB innoVation 7.89%0.09%
HLB 7.15% → HLB innoVation 16.07%1.15%

HLB Globaldirect 11.74%11.74%$7.7M

HLB Pharmaceuticaldirect 2.09% · indirect 0.17%2.26%$5.6M

Direct2.09%
HLB 7.15% → HLB Life Science 16.81% → HLB Pharmaceutical 14.05%0.17%

HLB Therapeuticsdirect 0.43% · indirect 1.30%1.73%$2.9M

Direct0.43%
HLB Pharmaceutical 2.09% → HLB Therapeutics 1.28%0.03%
HLB Global 11.74% → HLB Therapeutics 2.51%0.29%
HLB 7.15% → HLB Therapeutics 13.64%0.98%

N Citrondirect 2.76% · indirect 0.61%3.37%$2.2M

Direct2.76%
HLB Global 11.74% → N Citron 5.16%0.61%

HLB Genexdirect 2.16% · indirect 1.27%3.43%$1.8M

Direct2.16%
HLB Pharmaceutical 2.09% → HLB innoVation 7.84% → HLB Genex 6.18%0.01%
HLB innoVation 0.73% → HLB Genex 6.18%0.05%
HLB Panagene 1.30% → HLB Genex 6.24%0.08%
HLB 7.15% → HLB Genex 13.76%0.98%
HLB 7.15% → HLB Therapeutics 13.64% → HLB Genex 1.74%0.02%
HLB 7.15% → HLB Life Science 16.81% → HLB Genex 1.74%0.02%
HLB 7.15% → HLB Panagene 8.44% → HLB Genex 6.24%0.04%
HLB 7.15% → HLB innoVation 16.07% → HLB Genex 6.18%0.07%

HLB bioStepdirect 0.98% · indirect 1.06%2.04%$1.4M

Direct0.98%
HLB 7.15% → HLB bioStep 14.51%1.04%
HLB 7.15% → HLB Therapeutics 13.64% → HLB bioStep 1.84%0.02%

HLB Panagenedirect 1.30% · indirect 0.78%2.08%$749K

Direct1.30%
HLB bioStep 0.98% → HLB Panagene 7.14%0.07%
HLB 7.15% → HLB bioStep 14.51% → HLB Panagene 7.14%0.07%
HLB 7.15% → HLB Therapeutics 13.64% → HLB Panagene 1.30%0.01%
HLB 7.15% → HLB Panagene 8.44%0.60%
HLB 7.15% → HLB innoVation 16.07% → HLB Panagene 1.30%0.01%

HLB Pepdirect 0.50% · indirect 1.44%1.94%$493K

Direct0.50%
HLB Genex 2.16% → HLB Pep 11.13%0.24%
HLB bioStep 0.98% → HLB Pep 7.04%0.07%
HLB Panagene 1.30% → HLB Pep 4.20%0.05%
HLB 7.15% → HLB bioStep 14.51% → HLB Pep 7.04%0.07%
HLB 7.15% → HLB Genex 13.76% → HLB Pep 11.13%0.11%
HLB 7.15% → HLB Pep 11.64%0.83%
HLB 7.15% → HLB Life Science 16.81% → HLB Pep 2.78%0.03%
HLB 7.15% → HLB Panagene 8.44% → HLB Pep 4.20%0.03%

1 indirect-only holdings

No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.

HLB Life Scienceindirect 1.20%1.20%$2.8M

HLB 7.15% → HLB Life Science 16.81%1.20%

Indirect stakes multiply ownership through listed companies. Stakes through unlisted companies and holdings under 5% are not filed. Values overlap through subsidiaries, so do not add them up.